The receptor Slamf1 on the surface of myeloid lineage cells controls susceptibility to infection by trypanosoma cruzi by Calderón, Jossela et al.
The Receptor Slamf1 on the Surface of Myeloid Lineage
Cells Controls Susceptibility to Infection by Trypanosoma
cruzi
Jossela Caldero´n1,2, Elena Maganto-Garcia1¤a, Carmen Punzo´n1,2, Javier Carrio´n1¤b, Cox Terhorst3,
Manuel Fresno1,2*
1Centro de Biologı´a Molecular ‘‘Severo Ochoa’’ (CSIC-UAM), Universidad Auto´noma de Madrid, Cantoblanco, Madrid, Spain, 2 Instituto de Investigacio´n Sanitaria Princesa
(IP), Madrid, Spain, 3 The Division of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America
Abstract
Trypanosoma cruzi, the protozoan parasite responsible for Chagas’ disease, causes severe myocarditis often resulting in
death. Here, we report that Slamf12/2 mice, which lack the hematopoietic cell surface receptor Slamf1, are completely
protected from an acute lethal parasite challenge. Cardiac damage was reduced in Slamf12/2 mice compared to wild type
mice, infected with the same doses of parasites, as a result of a decrease of the number of parasites in the heart even the
parasitemia was only marginally less. Both in vivo and in vitro experiments reveal that Slamf1-defIcient myeloid cells are
impaired in their ability to replicate the parasite and show altered production of cytokines. Importantly, IFN-c production in
the heart of Slamf1 deficient mice was much lower than in the heart of wt mice even though the number of infiltrating
dendritic cells, macrophages, CD4 and CD8 T lymphocytes were comparable. Administration of an anti-Slamf1 monoclonal
antibody also reduced the number of parasites and IFN-c in the heart. These observations not only explain the reduced
susceptibility to in vivo infection by the parasite, but they also suggest human Slamf1 as a potential target for therapeutic
target against T. cruzi infection.
Citation: Caldero´n J, Maganto-Garcia E, Punzo´n C, Carrio´n J, Terhorst C, et al. (2012) The Receptor Slamf1 on the Surface of Myeloid Lineage Cells Controls
Susceptibility to Infection by Trypanosoma cruzi. PLoS Pathog 8(7): e1002799. doi:10.1371/journal.ppat.1002799
Editor: David L. Sacks, National Institute of Health, United States of America
Received February 4, 2012; Accepted May 30, 2012; Published July 12, 2012
Copyright:  2012 Caldero´n et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported in part by grants FIS (PI040993), Ministerio de Ciencia e Innovacio´n (SAF2005-02220, SAF2007-61716 and SAF2010-18733),
European Union (Eicosanox and ChagasEpiNet), CSIC-CONICET, BSCH/UAM, Comunidad de Madrid S2010/BMD-2332, RED RECAVA RD06/0014/1013 and RED
RICET RD06/0021/0016 to MF, a grant from the NIH to CT (AI-15066), and an institutional grant of Fundacion Ramon Areces. J.C. is a holder of a fellowship from
the Government of Panama. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: mfresno@cbm.uam.es
¤a Current address: Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America
¤b Current address: Facultad de Veterinaria, Universidad Complutense de Madrid, Spain
Introduction
American trypanosomiasis (Chagas’ disease) is caused by the
intracellular protozoan Trypanosoma cruzi that is transmitted to
vertebrate hosts by insect vectors belonging to the Reduviidae family
[1]. It is one of the most important parasitic infection in Latin
America affecting several million persons in South and Central
America [2] Due to the immigration Chagas’ disease is now
considered an emergent one in Europe [3]. The disease is a
complex zoonosis, with mammals as natural reservoir hosts.
Transmission is primarily by contact with the contaminated faeces
of domiciliated blood sucking triatomine bugs. The life cycle of this
parasite alternates between three morphologically distinct forms:
infective (metacyclic or blood trypomastigotes), insect borne
(epimastigotes) which replicate in the vector and intracellular
replicative (amastigotes) which grow and replicate intracellularly in
a variety of mammalian cells, including macrophages, cardiomy-
ocytes and muscle fibers [4–6].
Myocarditis is the most serious and frequent manifestation of acute
and chronic infection [2]. The pathogenesis is thought to be triggered
by parasites in the lesions and dependent on an immune-inflammatory
response to them [7–9]. Activation of a T helper type (Th1)
response, that release IFN-c and TNF, is required to activate the
microbicidal activity of macrophages important in the control of T.
cruzi infection [10,11]. Nonetheless, the development of severe
cardiomyopathy in Chagas’ disease is also thought to be due to a
Th1-specific immune response [12].
T. cruzi infects a variety of host cells, including macrophages and
cardiomyocytes. Several T. cruzi molecules, glycoproteins, trans-
sialidase and mucins among others, play a role in cell invasion
mainly interacting with TLRs or mannose receptors [13–17].
The Signaling Lymphocytic Activation Molecule family (Slamf)
receptors are adhesion molecules that are involved in signaling
between immune cells regulating for instance T cell proliferation,
antibody production, cytotoxic responses and cytokine production,
e.g. IFNc [18–25]. The self-ligand adhesion molecule Slamf1
(CD150) is not only a co-stimulatory molecule at the interface
between antigen presenting cells and T cells, but also functions as a
microbial sensor. For instance, Slamf1 also binds to the
hemaglutinin of Measles virus and to an outer membrane protein
of E.coli and S.typhimurium [26,27]. The latter interaction drives
Slamf1 into the E.coli phagosome where the receptor positively
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controls the microbicidal activity of macrophages by a signaling
mechanism that is distinct from its signaling as an adhesion
molecule [27]. Because Slamf1 partakes in bactericidal responses
as the receptor and plays a role in protecting against infection with
Leishmania major [23] we set out to evaluate how Slamf1-deficient
mice would respond to an infection by the intracellular parasite T.
cruzi. Surprisingly, we find that Slamf12/2 mice are resistant to a
lethal dose of T. cruzi, because the number of parasites in the heart
is greatly reduced as compared to infected wt mice. Further in vivo
and in vitro experiments revealed that T. cruzi has impaired ability
to replicate into Slamf1-deficient myeloid cells. Administration of
an anti-Slamf1 monoclonal antibody also reduced the number of
amastigotes in the heart.
Results
Slamf12/2mice survive an acute lethal infection by T. cruzi
Slamf12/2 and Slamf1+/+ BALB/c mice were infected with the
highly virulent T. cruzi Y strain. Interestingly, unlike wt mice,
Slamf12/2 mice did not die from the infection and eventually
recovered (Figure 1A). This complete resistance was observed also
with a very high parasite inoculum (104 parasites/mouse) (data not
shown). In the acute phase of the infection T. cruzi induces
myocarditis, which is thought to be the ultimate cause of mortality
[2,9]. Indeed the creatinine kinase (CK) levels, a marker of cardiac
damage, were significantly lower in the serum of infected Slamf12/2
mice than in Slamf1-sufficient BALB/c mice (Figure 1B), suggesting
that reduced heart damage was the cause of the survival of the
Slamf12/2 mice.
To assess the numbers of T. cruzi present in the heart of infected
wt and mutant mice, quantitative QC-PCR with parasite specific
probes was used. In BALB/c mice an increase in parasite load,
which follows parasitemia, peaked at 21 days postinfection (dpi).
By contrast, Slamf12/2 mice had a much smaller T. cruzi load in
their hearts (Figure 1C). Next, we performed histological analysis
of the infected hearts and compared the numbers of T. cruzi
amastigotes present in the cardiomyocytes of infected Slamf12/2
and Slamf1+/+ BALB/c mice. First, amastigote nests were less
frequently observed in the hearts of Slamf12/2 than of Slamf1+/+
mice and appeared to be smaller in size (Figure 1D). Furthermore,
the number of amastigote nests in Slamf12/2 mice from 7 dpi until
28 dpi was dramatically decreased compared to wt BALB/c mice
(Figure 1E), although the kinetics were similar as the maximum
number of amastigote nests was at 21 dpi, in close concordance
with the parasite DNA levels. In addition, at all time points, the
number of amastigotes per nest was lower in infected Slamf12/2
mice than in Slamf1+/+ BALB/c mice (Figure 1F). By contrast, the
number of parasites in the blood followed similar kinetics in both
mouse strains, although parasitemia was slightly lower than in
Slamf12/2 mice than in Slamf1+/+ BALB/c mice (Figure 1G).
Taken together, the data clearly demonstrate that infected
Slamf12/2 mice have much less T. cruzi amastigotes in their hearts
than Slamf1+/+ littermates, which is the most likely cause for the
survival of Slamf12/2 mice upon an acute infection by the parasite.
Leukocyte responses in the heart of Slamf12/2 mice
infected with T.cruzi
As reported previously [28], infection of BALB/c mice with T.
cruzi abrogates thymocyte development with kinetics closely
following the increased numbers of circulating parasites, as judged
by the loss of thymocyte numbers (Figure 2A). A reduction of the
CD4+ CD8+ double positive compartment was also observed
(Figure 2B), in agreement with the findings by Perez et al [29],
which could be caused by TNF, corticosteroids, parasite trans-
sialidase, extracellular ATP, androgens or galectin-3 [28,29].
However, in spite of the complete survival of the Slamf12/2 mice,
the kinetics of depletion of thymocyte subpopulations was identical
as that in wt BALB/c mice (Figure 2B). During infection of BALB/c
mice with T. cruzi splenic cellularity increased approximately 8-
fold (Figure 2C) By contrast, this expansion was only 3-fold in the
spleens from Slamf12/2 mice indicative of a much lesser activation
state at early times although at day 21 d.p.i. cellularity increases
were similar. Moreover, the distribution of leukocyte subpopula-
tions in spleens was similar in the Slamf12/2 and wt mice (Figure
S1). Taken together, the data indicate that the difference in
susceptibility of Slamf12/2 and wt BALB/c mice could not be
attributed to selective differences in the alterations of major
leukocyte subpopulations in those organs affected by the infection.
One of the key contributors to the cardiomyopathy during
infection with T. cruzi is thought to be the infiltration by CD8 T
lymphocytes, which as a consequence of a immune reactivity to
the parasite produce an inflammatory milieu that is detrimental
for heart function [8]. We therefore determined CD8 infiltration
into the heart of infected mice by mRNA levels of subpopulation-
specific cell surface markers [30]. CD8 infiltration increases
constantly into the hearts of BALB/c mice until their death
(Figure 3A). However, no significant differences were observed in
the kinetic of CD8 infiltration (7 to 21 dpi) between Slamf12/2
and BALB/c mice except for a small decrease in CD8 T cell
infiltration at 28 dpi, likely reflecting the resolution of infection in
this strain of mice (Figure 3). Similarly, no significant differences
were observed in the kinetics of CD4 T lymphocyte infiltration
(Figure 3A). Uninfected hearts have no detectable mRNA of those
markers.
We evaluate whether myeloid cells infiltration into the heart was
different between T.cruzi-infected mutant and wt mice using a
similar approach. As previously shown [30], macrophage (CD68)
and dendritic cell (CD11c) infiltration into the heart of wt mice
infected with the parasite peaks at 21 days post-infections
(Figure 3A). However, only statistically significant modest decrease
in CD68+ macrophage infiltration at later times after infection
Author Summary
Chagas’ disease caused by the intracellular protozoan
Trypanosoma cruzi is the most important parasitic infection
in Latin America affecting several million persons. None-
theless, there is no therapy or vaccine available. Thus,
more efforts are needed to identify new therapeutic
targets. Here, we report that Slamf1, which controls
phagosomal/lysosomal fusion and phagosomal NADPH-
oxidase activity, is required for T.cruzi replication in
macrophages and dendritic cells, but not in other cells,
which do not express the receptor. In the absence of
Slamf1 we detect reduced number of parasites in the heart
compared to infected wt mice. This explains why T. cruzi-
infected Slamf1 deficient mice do not succumb to
myocarditis induced by a lethal challenge with T. cruzi in
contrast to BALB/c mice. Perhaps more importantly, we
demonstrate that parasite replication in phagocytes is of
far greater importance for the pathogenesis of the
cardiomyopathy than replication in other cells. Moreover,
we found much lower IFN-c production in the heart of
Slamf1 deficient mice than in the heart of BALB/c mice. We
corroborated those results using an alternative approach,
blocking Slamf1 function in vivo by treating mice with
anti-Slamf1 antibodies. Consequently, Slamf1 is an attrac-
tive novel therapeutic target for modulating T. cruzi
infection.
Slamf1 Is Required for T. cruzi Infection
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Figure 1. Time-course of T. cruzi infection in Slamf12/2 mice and reduced T. cruzi infection in the hearts from Slamf12/2 animals.
BALB/c or Slamf12/2 mice were intraperitoneally infected with 26103 trypomastigotes of the T. cruzi Y strain and were sacrificed at different dpi. A)
Survival. B) Serum CK levels. Analysis of T. cruzi presence in heart tissue from T. cruzi infected BALB/c or Slamf12/2 animals: C) Quantification of T. cruzi
Slamf1 Is Required for T. cruzi Infection
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(28 dpi) into the hearts of infected Slamf12/2 compared to
BALB/c mice were observed. Those results were confirmed using
confocal microscopy of the infected hearts with specific antibodies.
No statistically significant differences in CD4, CD8 or CD68
infiltration and a slight increase in CD11c were observed at 21 dpi
(Figure 3B).
Taken together, these data indicate that the striking difference
in susceptibility of Slamf12/2 and wt BALB/c mice could not be
attributed to differences in the recruitment of effector CD8 or
CD4 T cells or myeloid cells into the heart.
Deviation of cytokine responses in the heart of Slamf12/
2 mice infected with T. cruzi
We next tested the levels of cytokines in the hearts by QC-PCR.
In BALB/c mice, T. cruzi infection is accompanied by an increase
in the heart of pro-inflammatory mediators TNF, IL-6 and IFNc
as well as anti-inflammatory mediators, e.g. IL-10 and arginase I
[30,31]. However, a significant reduction in IFNc and IL-10
mRNA in the hearts of infected Slamf12/2 mice, as compared to
BALB/c, was observed (Figure 4), TGF-b, IL-4 and IL-13, TNFa
and IL-6 mRNA levels were no different to those in wt mice
(Figure 4 and Figure S2). Interestingly, lower levels of arginase I
mRNAs were also observed in Slamf12/2 mice especially at the
peak of parasite load 21 dpi (Figure 4C), consistent with our
previous finding that sustained arginase I expression through the
acute infection is detrimental for the host [31].
In contrast, systemic cytokine production detected in the sera of
infected mice was not different (Figure S3), once again indicating
again that changes in systemic immune responses are not
responsible for the reduced susceptibility of Slamf12/2 mice to
T. cruzi infection.
Reduced replication of T. cruzi in Slamf12/2macrophages
An additional, and perhaps more relevant, explanation for the
reduced amastigote content in the hearts of Slamf12/2 mice,
could be that intracellular T. cruzi replication was impaired in the
mutant mice. To address this hypothesis, we analyzed macro-
phages isolated from the peritoneum of mice that were infected
with T. cruzi. Adherent peritoneal cells from 7 dpi to 28 dpi of
infected BALB/c mice contain intracellular amastigotes, with a
number that peaked at 21 dpi when approximately 50% of the
peritoneal macrophages from BALB/c mice are infected by T. cruzi
(Figure 5A and B). Those infected cells at 21 dpi contained 30
amastigotes. On average, by contrast, a maximum of only 20% of
adherent cells from the peritoneal fluid of Slamf12/2 mice borne
the parasite, with a maximum of 15 amastigotes/cell at 21 dpi
(Figure 5B). Combining those 2 parameters, the reduction in
amastigote content in peritoneal cells isolated from Slamf12/2
mice was greater than 75% as compared with wt mice. Thus,
peritoneal macrophages isolated from T.cruzi infected Slamf12/2
mice appeared to replicate the parasite less efficiently.
To corroborate this observation, we tested whether in vitro T. cruzi
infection was impaired in isolated Slamf12/2 macrophages,
dendritic cells (DC) or cardiomyocytes. Forty-eight hours after
infection replication of the parasite and the generation of amastigotes
was detected in wt cells (Figure 5C). However, Slamf12/2
macrophages (Figure 5C) and DCs (Figure 5D) were far less effective
in supporting T. cruzi replication then wt cells. In contrast to myeloid
cells, Slamf12/2 and wt cardiomyocytes were equally susceptible to
in vitro infection with T. cruzi (Figure 5E and F).
Next, we analyzed whether Slamf1 deficiency alters myeloid cell
response to the parasite. As expected, T. cruzi infection of wt
macrophages triggered the production of inflammatory mediators
inducible nitric oxide synthase (iNOS Nos2) and cyclooxygenase-2
(COX-2, Ptgs2) at the mRNA and protein level (Figure 6A). Also
arginase 1, Arg1, mRNA was induced upon infection. In contrast,
T. cruzi infection of Slamf12/2 macrophages and show reduced
levels of Ptgs2, Nos2 and Arg1 mRNAs. Moreover, infected
Slamf12/2 macrophages release less IFNc into the supernatant
than infected BALB/c macrophages but similar levels of TNF
(Figure 6B). Similarly, upon T. cruzi infection Slamf12/2 DC also
produced less IFNc and IL-12 than wt BALB/c DCs (Figure 6C).
Not surprisingly, because cardiomyocytes do not express Slamf1,
upon infection with T. cruzi these cells, whether isolated from wt or
Slamf12/2 BALB/c mice, produced equal amounts of IFNc and
nitric oxide (NO) upon in vitro infection (Figure 6D). Taken
together, the outcomes of these experiments support a model in
which T. cruzi replication is reduced and cytokine production is
altered when Slamf1 is absent in macrophages and DCs.
A monoclonal antibody directed against Slamf1 reduces
the number of T. cruzi amastigotes in the heart
To test this concept we employed an alternative approach,
namely administering an anti-Slamf1 monoclonal antibody to
infected BALB/c mice once a week during the four weeks post
infection with T. cruzi. We used a lower parasite inoculum than in
Slamf1 KO mice in order to increase the survival and to allow the
action of the antibody. Based on analysis of parasite DNA
(Figure 7), the number of amastigotes in the heart was significantly
reduced in antibody treated mice as compared to mice that had
received an isotype control. In addition IFNc mRNA levels were
also partially reduced in a similar fashion. As in the Slamf12/2
mouse the monoclonal antibody directed against Slamf1 did not
affect the parasitemia in the blood (data not shown). Thus, the
antibody experiments directly support the conclusions that are
based upon the experiments obtained with Slamf12/2 mice.
Discussion
The current studies led the concept that Slamf1 is required for
replication of T.cruzi in macrophages and DCs, but not in other
cells, which do not normally express the receptor, e.g. cardiomy-
ocytes. Besides, in the absence of Slamf1, macrophages and DCs
produce less myeloid cell specific factors that are key in influencing
the host response to parasite and eventually the outcome of the
infection. This explains why T. cruzi infected Slamf12/2 mice do
not succumb to myocarditis induced by a lethal challenge with the
highly virulent T. cruzi Y strain quite the opposite to BALB/c mice
even with similar parasitemia levels. The later also indicates that
parasitemia does not necessarily need to be related to cardiomy-
opathy, which is the leading cause of death upon T.cruzi infection
in most instances [2,9].
DNA in the heart tissue of infected BALB/c- and Slamf12/2mice. T. cruzi DNA is expressed as the amount of parasite DNA obtained from a heart tissue
sample (pg of parasite DNA/mg of heart tissue). Results are expressed as the mean values (6SD) for triplicates of pooled DNA from 5 different mice. A
representative experiment of the 3 performed is shown. D) Histochemical analysis by Hematoxylin-Eosin stain. A representative field is shown. E)
Quantification of the number of amastigote nests per 20 fields. F) Average number of amastigotes/nest per 20 fields. At least 20 fields were observed
of each preparation (3 preparations/mouse and 3 mice per group). Results are expressed as the mean values (6SD) for 100 independent microscopic
fields from 5 different mice (20 each). G) Blood parasitemia. (*) Statistically significant differences between Slamf12/2 mice and BALB/c (p.0.05).
doi:10.1371/journal.ppat.1002799.g001
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Our results also show that the systemic alterations previously
reported associated to T. cruzi infection and suggested to play a
role in pathology as impairment of thymocyte development
[28,32] or altered systemic cytokine production, among others
[9], were not different in both infected Slamf12/2 mice and
control Slamf1+/+ mice, indicating that those major changes in
systemic immune responses are not responsible for the reduced
susceptibility of Slamf12/2 mice to T. cruzi infection. Rather, the
altered local heart response to infection, with much lower T. cruzi
amastigotes and altered immune mediators in infected Slamf12/2
mice, are the most likely cause for the survival of Slamf12/2 mice
upon an acute infection by the parasite.
We favor an interpretation of our observations that in Slamf12/2
mice less T. cruzi parasites enter the heart. However, as circulating
parasite levels are similar in Slamf12/2 mice and the in vitro
susceptibility of cardiomyocytes to infection is not altered by Slamf1
deficiency, is likely that T. cruzi blood trypomastigotes are unable to
penetrate the heart directly to infect the cardiomyocytes. On the
other hand, T. cruzi replicate much less well in Slamf12/2 DC and
macrophages than in the equivalent wt cells. Although Slamf1 is
expressed on the surface of hematopoietic stem cells, a careful analysis
of Slamf12/2 on two genetic backgrounds has not revealed any
abnormalities in hematopoiesis included myeloid cells [23,27]. It is
therefore unlikely that a major defect in myeloid development and
differentiation in Slamf12/2 mice has an effect on T.cruzi infection.
Thus, despite comparable infiltration of macrophages and DCs
between infected Slamf12/2 mice Slamf12/2, the number of
infective amastigotes that are carried into the heart by infected
migrating Slamf12/2 monocytes, DCs or macrophages will be
greatly reduced and might be one of the contributing factors to the
survival of Slamf12/2 mice to infection with the parasite. In
addition, it is also possible that homing of infected monocytes or
macrophages into the heart is affected by the absence of Slamf1.
Together, our results suggest that DC and myeloid cells can act as
a ‘‘Trojan horse’’ for T. cruzi infection into the heart.
An alternative interpretation is that the reduced amastigote
number in the heart of Slamf12/2 mice is a result of a stronger
response to T. cruzi that limits its replication. Collectively, our results
argue against this, since immune cells infiltrate the heart of a
Slamf12/2 mouse in a similar fashion as in a BALB/c mouse and
the amounts of key cytokines produced in the heart are equal or
lower than in the wtmouse. Thus, although IFNc-producing CD8T
cells may enter the heart from the circulation to eliminate T. cruzi
infected cells [33], in Slamf12/2mice similar numbers of CD8 cells
infiltrate the heart, but produce less IFNc due to lower antigenic
stimulus. Moreover, arginase I levels are lower in the heart of
Slamf12/2 mice, and we have found that the levels of this enzyme
presents in infiltrating myeloid suppressor cells correlate with higher
susceptibility to infection [31]. This reduction may also contribute
to explain the lower susceptibility of Slamf12/2 mice.
Parasitemia levels are similar in both mice strains. This fact
suggests that circulating parasite levels are mostly due to
replication of T. cruzi in other organs and cells others than
myeloid cells. T. cruzi are known to replicate in many cell types,
including muscle, epithelial and endothelial cells [9,34]. Since
Slamf1 is only expressed in myeloid cells, the replication of T. cruzi
in non-hematopoietic cells is not likely to be impaired in Slamf12/2
mice and hence the blood-borne parasitemia is only slightly less in
the mutant mice.
Previously, Slamf1 was found to be a requisite for the
elimination of the T. cruzi-related intracellular protozoa (Leishmania
major) by B6 mice [23]. However, Slamf12/2 BALB/c mice
respond to a L. major infection in an identical fashion as wt BALB/c
animals. The role of Slamf1 in the response to the two related
Figure 2. Immunologic populations from lymphoid organs of T.
cruzi-infected mice. Thymocytes were isolated from thymus from
control NI or T. cruzi infected BALB/c or Slamf12/2 mice at 14 and
21 dpi. A) Total number of thymocytes isolated from NI or infected
mice. Results are expressed as the mean values (6SD) for triplicates and
from 5 different mice. B) CD4 and CD8 thymocytes in infected mice.
Thymocytes were analyzed by two-color flow cytometry. Numbers
represent % of CD4, CD8 SP, DP or DN thymocytes. Thymocytes from 5
mice in each group were pooled and analyzed. C) Spleens were isolated
from infected mice and the total number of lymphocytes/spleen was
quantified. Results are expressed as the mean values (6SD) for
triplicates and from 5 different mice. (*) Statistically significant
differences between Slamf12/2 mice and BALB/c (p.0.05).
doi:10.1371/journal.ppat.1002799.g002
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Figure 3. Heart leukocyte infiltration during T. cruzi infection. Cell populations in mouse heart tissue during T. cruzi infection. A) Cell subset
infiltration quantified by QC-PCR. Total RNA was isolated in heart tissue obtained from mice at different dpi, and quantitative reverse-transcriptase
polymerase chain reaction was performed as described in Materials and Methods. Results are expressed as the logarithm of relative quantity (RQ)
calculated from comparative threshold cycle values, as described in Material and Methods. mRNAs values are shown for DCs (CD11c), CD4 and CD8 T
lymphocytes and macrophages (CD68). Results are expressed as the mean values (6SD) for triplicates of pooled DNA from 3 different mice. A
representative experiment of the 3 performed is shown. B) Evaluation of infiltrating subpopulations by confocal analysis. Hearts were fixed and
Slamf1 Is Required for T. cruzi Infection
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parasites is therefore different, as Slamf1 plays a detrimental role
in T. cruzi infection of BALB/c mice. Consequently the
mechanisms involved are likely to be different. In Leishmania
infection the susceptibility of Slamf12/2 mice has been linked to a
depressed NO production by macrophages, with a consequent
inability to eliminate the parasite. NO is also required for T. cruzi
killing [10] and we also found that T. cruzi infection in Slamf12/2
macrophages does not trigger iNOS, but this has no apparent
impact for ‘‘in vitro’’ or ‘‘in vivo’’ replication. The reasons for this
apparent discrepancy may lie in the fact that Slamf1 affects a
different and earlier process in the infection of macrophages by T.
cruzi than L. major, as the two parasites invade the cells by different
mechanisms.
Besides, Slamf12/2 mice are also more susceptible to an
attenuated strain of S. tyhimurium Sseb-e [27] contrary to T. cruzi.
Although it might at face value appear paradoxical those
contrasting effects one should keep in mind that in humans
Slamf1 is one of the two receptors (probably the original receptor)
for Measles virus [26,27]. Therefore the virus and the parasite
utilize an important receptor system to their advantage.
The diminished replication of T. cruzi in Slamf12/2 myeloid
cells may explain, at least partially, the lower susceptibility of
Slamf12/2 mice. Although, the mechanism by which Slamf1
reduce T. cruzi replication has not been addressed in this
manuscript, previous experiments demonstrated that Slamf1 is
involved in entering E.coli into phagosome, where it governs
phago-lysosomal maturation and NADPH-oxidase (Nox2) activity
[27]. This is caused by a reduction in of phosphatidyl-inositol 3-
phosphate production, which is synthesized by the intracellular
Class II PI3-kinase (PI3K) Vps34. As T. cruzi requires phagosome
formation and PI3K (Vps34) activation to invade macrophages
stained with anti-CD4, CD8, CD68 and CD11 as described in Methods. Results shown are the mean number of cells (6SD) per 10 fields (20
independent microscopic fields from 3 different mice were counted). (*) Statistically significant differences between Slamf12/2mice BALB/c (p.0.05).
doi:10.1371/journal.ppat.1002799.g003
Figure 4. Heart cytokine and immune modulator production by T. cruzi infected mice. Cytokine mRNA production in the heart of T. cruzi
infected mice was evaluated by QC-PCR as described in Methods. Total RNA was isolated in heart tissue obtained from BALB/c and Slamf12/2mice at
different dpi, and quantitative reverse-transcriptase polymerase chain reaction was performed as described in Materials and Methods. Results are
expressed as the logarithm of relative quantity (RQ) calculated from comparative threshold cycle values, as described in Material and Methods. (*)
Statistically significant differences between Slamf12/2 mice and BALB/c (p.0.05).
doi:10.1371/journal.ppat.1002799.g004
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[17,35], it is therefore likely that Slamf1 participates with other
molecules/receptors in the entry of T. cruzi into the phagosome.
Moreover, a recent study shows that Nox2 inhibition amelio-
rates T. cruzi-induced myocarditis independently of parasitemia
levels [36] as in Slamf12/2 mice. Thus, a reduced Nox-2
production together with a reduced replication in myeloid cells are
the underlying mechanisms, which may explain the survival of
Slamf12/2 mice to T.cruzi infection.
Interestingly, anti-Slamf1 treatment might affect the same
processes. Consequently, Slamf1 is a key molecule in T. cruzi
infectivity and represents an attractive novel therapeutic target for
modulating T. cruzi infection and Chagas’ disease.
Figure 5. Slamf1 deficient myeloid cells are less susceptible to T. cruzi infection. Mice were intraperitoneally infected with T. cruzi and at 0,
7, 14, 21 and 28 dpi mice were sacrificed. A) Giemsa staining of adherent peritoneal macrophages from Slamf12/2 and BALB/c animals were isolated
by intraperitoneal lavage with PBS and stained. A representative field is shown. B) Quantification of infected adherent cells in the peritoneal lavages.
Quantification of the number of amastigotes nests per 20 field and average number of amastigotes/nest per 20 fields. Results are expressed as the
mean values (6SD) for 100 independent microscopically fields from 5 different mice (20 each). C) Peritoneal macrophages and D) DC cells from BALB/
c and Slamf12/2 mice were infected in vitro with T. cruzi (10 parasites/cell). The number of amastigotes released to the supernatant after 48 of
infection was estimated by counting them by optical microscopy. Results are expressed as the mean values (6SD) for triplicates from 3 different
experiments. E and F) Neonatal cardiomyocytes were infected ‘‘in vitro’’ with T. cruzi and 72 h postinfection analyzed by Giemsa staining.
Quantification of the number of infected cardiomyocytes per field (E) and average number of amastigotes/cardiomyocyte (F). Results are expressed as
the mean values (6SD) for 100 independent microscopic fields from 5 different mice (*) Statistically significant differences between Slamf12/2 mice
and BALB/c (p.0.05).
doi:10.1371/journal.ppat.1002799.g005
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Figure 6. Cytokine production and immune modulators by ‘‘in vitro’’ T. cruzi infected DC, macrophages or cardiomyocytes.
Peritoneal macrophages, DC or cardiomyocytes from Slamf12/2 from BALB/c mice were infected in vitro with T. cruzi. A) Cox-2, iNOS and Arginase
mRNA, evaluated by QC-PCR production (upper graphs) and protein by western blot (lower gels) by infected macrophages at 24 or 48 hr post
infection as described in Methods. B) Cytokine (IFN-c and TNF) release to supernatants from infected macrophages was evaluated by ELISA 24 or
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Materials and Methods
Ethics statement
The animal research described in this manuscript complied with
Spanish (Ley 32/2007) and European Union legislation (2010/
63/UE). The protocols used were approved by the Animal Care
Committee of the Centro de Biologia Molecular and Universidad
Autonoma de Madrid.
Parasites, mice and infections
T. cruzi Y strain epimastigotes were cultured in liver-infusion
tryptose medium (LIT) supplemented with 10% FCS. Epimasti-
gotes were differentiated into infective metacyclic trypomastigotes
in GRACE medium (GIBCO BRL, Gran Island, NY) supple-
mented with 10% FCS for 10–12 days as described [17]. Blood
trypomastigotes were maintained by weekly i.p. inoculations to
BALB/c mice in our animal facilities. Six to 8-week-old BALB/c
and Slamf12/2 mice [23], crossed 10 times with BALB/c mice as
described, were maintained under pathogen-free conditions. Mice
were infected i.p with 26103 typomastigotes of the Y strain and
parasitemia was measured as described [37]. Animals were also
infected i.p with 16102 typomastigotes and treated with the rat-
anti-mouse Slamf1 antibody (9D1) or control rat antibody;
0.5 mg/mouse before the infection and then once a week.
Cell cultures and infection
Neonatal, mouse primary cardiomyocyte cultures were obtained
as described [30,38]. More than 90% of cells were cardiomyocytes
as detected by immunostaining with antibody to mAchR M2 as
described [39]. After 24 h, the cultures were infected with T. cruzi
as described. Spleen from infected or control mice were isolated as
described [17]. Thymic cells were also obtained as described [40]
and cells harvested and centrifuged three times in phosphate
buffered saline containing 2% bovine serum albumin (Sigma) and
0.1% sodium azide. Later they were analyzed by flow cytometry
using double immunofluorescence staining with phycoerythrin
(PE)-anti-CD4 and fluorescein isothiocyanate (FITC)-anti-CD8a
(Becton Dickinson).
Spleen cells were stained for flow citometry using monoclonal
antibodies against CD45R/B220, CD11b, CD11c, CD4 and CD8
(BD Biosciences). All samples were acquired in a FACSCalibur
cytometer (BD Biosciences) and analysed by using Flowjo 4.1
software (Tree Star, Inc).
Peritoneal cells from infected mice were collected with 0.34 M
sucrose. Cells were then plated in complete RPMI with 5% FBS.
After 4 h, non-adherent cells were removed by washing three times
with warm PBS, and fresh complete RPMI was restored. Cells were
analyzed by Giemsa staining under a light microscope. For in vitro
infection, primary macrophages were isolated by peritoneal lavage
of mice 4 days after a single intra-peritoneal injection of 10%
thioglycolate solution (1 ml; Difco Laboratories). Cells (1.56106/
well) were allowed to adhere for 1 h in 12-well flat-bottomed plates
in RPMI 0,5% FCS. Cells were co-cultured with T. cruzimetacyclic
trypomastigotes (10 parasites/cell) for 4 h to allow binding and
internalization and macrophages were washed with PBS four times
to remove unbound parasites. Cells were analyzed 24 h and 48 h
Figure 7. Anti-Slamf1 antibodies reduce heart parasite load. BALB/c or Slamf12/2 mice were intraperitoneally infected with 16102
trypomastigotes of the T. cruzi Y strain and treated with anti Slamf1 or control antibodies (0.5 mg/mouse once a week). At different dpi mice were
sacrificed. A) T. cruzi DNA was quantified in the heart tissue of infected mice and expressed as the number of picograms of parasite DNA per milligram
of DNA obtained from a heart tissue sample. Results are expressed as the mean values (6SD) for triplicates of pooled DNA from 5 different mice. A
representative experiment of the 2 performed is shown. B) IFN-c mRNA production in the heart of T. cruzi infected mice. Total RNA was isolated in
heart tissue at different dpi, and quantitative reverse-transcriptase polymerase chain reaction was performed as described in Materials and Methods.
Results are expressed as the logarithm of relative quantity (RQ) calculated from comparative threshold cycle values, as described in Material and
Methods. (*) Statistically significant differences between Slamf12/2 mice and BALB/c (p.0.05).
doi:10.1371/journal.ppat.1002799.g007
48 hr post infection as described in Methods. C) Cytokine (IFN-c and IL-12) release to supernatants from infected DCs was evaluated by ELISA 24 or
48 hr post infection as described in Methods. D) IFN-c and NO production by infected cardiomyocytes. NO was evaluated by Gris reaction and IFN-c
by ELISA. Results are expressed as the mean values (6SD) for triplicates from 3 different experiments. (*) Statistically significant differences between
Slamf12/2 and BALB/c cells (p.0.05).
doi:10.1371/journal.ppat.1002799.g006
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post infection for gene expression by RT-PCR or cytokine
production by ELISA in the supernatants. IL-2, IL-12, IL-10,
IFN-c, TNF, IL-6, IL-17A and IL-4 in cell culture supernatants or
in serum samples were evaluated using ELISA kits from R&D
systems following manufacturer instructions.
Dendritic cells were obtained from bone marrow from the
femur and tibia of mice was flushed of the hind limbs with ice cold
PBS (phosphate-buffered saline), was centrifuged and resuspended
into RPMI 1640 (GIBCO) 5% FBS (complete medium) supple-
mented with 20 ng/ml of recombinant murine GM-CSF (Pepro-
tech) at 37uC, 5% CO2. Each three days 25 ml fresh medium was
added with the same concentration of GM-CSF. At day 7 the
medium was collected, centrifuged and the pellet resuspended in
fresh medium. 16106 cells were plated in 6- well plates overnight
in complete medium. Then, the cells were co-cultivated with T.
cruzi trypomastigotes (10 parasites/cell) for 4 hours. After this time
the cells were washed to remove the remaining parasites and they
were incubated in fresh complete medium for the indicated time.
Western blotting
Cells were lysed in NP-40 buffer (20 mM Tris- Hal pH 7.4, 1%
Triton X-100, 150 mom Nail, 0.5% deoxyglycolate, 0.1% SDS
and 10 mM NaF; the protease inhibitors aprotinin and leupeptin
at 2 mg/ml, 1 mg/ml pepstatin and 1 mM PMSF; and 100 mM
of the phosphatase inhibitor Na3VO4) for 30 min at 4uC, and
supernatants were collected after centrifugation. The extracts
(20 mg) were separated by SDS-PAGE (10% polyacrylamide) and
subjected to Western blot with the appropriate antibodies for 1 h.
Membrane was incubated with secondary antibody coupled to
peroxidase and was revealed by Supersignal reagent (Pierce) and
protein detected by autoradiography.
Real time PCR for parasite DNA detection and mRNA
analysis by quantitative RT-PCR
Parasite DNA was isolated from heart tissue after blood perfusion
with the High Pure PCR Template preparation Kit (Roche) and
PCR reactions were conducted with 100 ng of the DNA as
described [31]. For T. cruzi detection, we followed the method
described by Peron et al. [41]. Heart RNA was extracted with
TRIzol reagent (Invitrogen).Quantitative RT-PCR analysis was
done with High Capacity cDNA Archive Kit (Applied Biosystems)
and amplification of different genes (ArgI, inos2, B220, CD11c, CD4,
CD8, CD68, Ifng, Tnf, il4, il10, il13, il12, ptgs2 and 18SrRNA) was
performed in triplicate using TaqMan MGB probes and the
TaqMan Universal PCR Master Mix (Applied Biosystems) on an
ABI PRISM 7900 HT instrument (Applied Biosystems) as described
[30]. Quantification of parasite DNA and gene expression by real-
time PCR was calculated by the comparative threshold cycle (CT)
method, normalized to the ribosomal 18S control and efficiency of
the reverse transcription reaction (RQ= 22DDCT). (Fold-change).
Graphs were plotted as log RQ when indicated.
Creatine Kinase (CK) assay
The activity of CK-MB isoenzyme, one of myocardial injury
marker, was measured with commercial kits (EnzyChrom – ECPK-
100, BioAssay Systems, USA) as described by the supplier. Incubation
of serum samples with the substrate led to a net increase in NADPH
concentration, directly proportional to the enzyme activity in the
samples. The assay was adapted for reading in a microplate
spectrophotometer (Microplate Nunclon Surface; FLUOstar Opti-
ma-BMG-Latch), to allow the study of small quantities of mouse
serum according to the manufacturer’s recommendation. The optical
density at 340 nm was recorded at 10 min and again at 40 min.
Histological analysis of heart
The hearts of mice infected or not were fixed in 10% neutral
buffered paraformaldehyde, and embedded in paraffin. Longitudinal
cuts of 5 mm thick were mounted on glass slides and stained with
Haematoxylin-Eosin. The number of amastigote nests was estimated
by observing 20 fields per preparation (each in triplicate) using the
Lexica light microscope at a resolution of 6306. Hearts were also
analyzed by confocal immunofluorescence as described [30]. Briefly,
hearts were fixed in 4% paraformaldehyde in PBS solution, incubated
in 30% sucrose solution, embedded in Tissue-Tek O.C.T. compound
(Sakura) and frozen. Incubation with the following antibodies was
done at 4uC: rat anti–mouseCD68-Alexa 594 (Serotec), goat anti-
mouse CD11c-Alexa 555 (Santa Cruz), rat anti-mouse CD4-Alexa
647 (BD Pharmingen) and rat anti-mouse CD8-Alexa 594 (e-
Bioscience). Images were obtained using an LSM510 Meta.
Statistical analysis
For in vivo experiments, data reported are means 6 SD from
triplicate determination of a representative experiment out of at
least three (n#5). Results shown from in vitro experiments are
representative of at least three experiments performed in duplicate.
Significance was evaluated by Student’s two-tailed t-test; all
differences mentioned were significant compared to controls
(p,0.05 or p,0.01).
Supporting Information
Figure S1 Spleen cell populations in infected mice.
Splenocytes were isolated from thymus from control NI or T. cruzi
infected BALB/c or Slamf12/2 mice at 14 and 21 dpi. The
percentage of major leukocyte subpopulations in the spleen was
assessed by flow cytometry. Results are expressed as the mean values
(6SD) for triplicates and from 5 different mice in each group.
(TIF)
Figure S2 Heart cytokine production by T. cruzi
infected mice. Cytokine mRNA production in the heart of T.
cruzi infected mice was evaluated by QC-PCR as described in
Methods. Total RNA was isolated in heart tissue obtained from
BALB/c and Slamf12/2 mice at different days post infection (dpi),
and quantitative reverse-transcriptase polymerase chain reaction
was performed as described in Materials and Methods. Results are
expressed as the logarithm of relative quantity (RQ) calculated
from comparative threshold cycle values, as described in Material
and Methods.
(TIF)
Figure S3 Cytokine production in the serum of infected
mice. The levels of different cytokines (IFN- c, TNF, IL-2, IL-4,
IL-6, IL-10, IL-12 and IL-17A) were quantified in blood of control
and infected mice by flow cytometry following the instructions
indicated by the supplier (Cytometric Bead Array-Becton Dick-
inson). Results are expressed as the mean values (6SD) for
triplicates from 3 different mice. A representative experiment of
the 3 performed is shown. (*) Statistically significant differences
between Slamf12/2 mice and BALB/c (p.0.05).
(TIF)
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